drugset / Trial / NCT02655653

Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery

NCT02655653

Phase 3 Completed 114 enrolled Montefiore Medical Center
RandomizedParallel-groupTriple-blindSupportive care

Summary

The investigators primary objective is to compare the effectiveness of epsilon-aminocaproic acid (EACA) and tranexamic acid (TA) in reducing bleeding and transfusion in cardiac surgery, with the hypothesis that TA is more effective. The investigators also seek to further examine the clinical benefits and adverse effects profiles of epsilon-aminocaproic acid and tranexamic acid.

Timeline

Start
2008-10
Primary completion
2010-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminocaproic Acid Small molecule 15 mg/kg
Subject Tranexamic Acid Small molecule 16 mg/kg

Indications